Babak Alavynejad, DPM
Foot & Ankle Surgery · West Covina, CANPI 1003984436
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (44.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Empire Medical, Inc at 44.6% of the total. Reporting peaked in 2022 at $1,424 and has fallen 99.2% since, to $12 in 2025.
Across 60 payments — averaging $44.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Empire Medical, Inc$1K
- Smith+Nephew$638
- Arthrex$560
- Cardiovascular Systems Inc.$97
- Angiodynamics, Inc.$63
- Integra Lifesciences Corporation$53
- plus $81 from 4 others
Across 18 payments — averaging $9025.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Endo Pharmaceuticals Inc.$101K
- Vertex$62K
What the payments were for
- Travel & lodging$35913%
- Food & beverage$1,13342%
- Education$1,20045%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Empire Medical, Inc | 1 | $1,200 |
| Smith+Nephew | 41 | $638 |
| Arthrex | 7 | $560 |
| Cardiovascular Systems Inc. | 2 | $97 |
| Angiodynamics, Inc. | 1 | $63 |
| Integra Lifesciences Corporation | 2 | $53 |
| DJO, LLC | 2 | $39 |
| ERMI LLC | 1 | $17 |
| Merck | 1 | $13 |
| Electronic Waveform Lab, Inc. | 2 | $12 |
How this compares
$2,692 in reported general payments places this provider in the 55th percentile of 1,126 foot & ankle surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 51 | $1,156 |
| Ketoconazole | 30 | $896 |
| Clotrimazole | 12 | $389 |
| Diclofenac Sodium | 24 | $372 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in West Covina
- Eric GizaSacramento$3.6M
- Thomas HarrisPasadena$3M
- Thomas ChangSanta Rosa$2M
- Michael CoughlinSan Francisco$1.6M
- Vladimir ZeetserEncino$677K
- Jason NowakRedding$526K
- Candice BradyCamarillo$462K
- Andrew HsuOrange$456K
- Eric TanLos Angeles$447K
- Joseph ParkBurbank$387K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.